Research Article

Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality

Table 1

Patient characteristics by weekly epoetin-α dose categories.

TotalAveraged weekly epoetin-α dose during follow-up period (U/week)
<6 0006 000 to <12 00012 000 to <18 00018 000 to <24 00024 000 to <30 000≥30 000

(%)128 598 (100)6 644 ()23 314 ()26 852 ()21 487 ()15 278 ()35 023 ()
Age (yr)62 ± 1562 ± 1663 ± 1562 ± 1562 ± 1562 ± 1560 ± 15
Female (%)70 309 (55)4 191 (63)13 107 (56)14 604 (54)11 541 (54)8 153 (53)18 713 (53)
Dialysis vintage (mo)3 (1,28)16 (2,39)7 (1,30)4 (1,27)2 (1,26)2, (1,25)2 (1,26)
Race (%)
 Caucasian55 107 (43)3 181 (48)10 057 (43)11 026 (41)9 072 (42)6 460 (42)15 311 (44)
 African American41 257 (32)1 678 (25)6 286 (27)8 104 (30)6 775 (32)5 173 (34)13 241 (38)
 Hispanic18 409 ()968 ()4 032 ()4 384 ()3 336 ()2 116 ()3 573 ()
 Asian3 887 ()218 ()885 ()1 002 ()675 ()436 ()671 ()
 Other9 938 ()599 ()2 054 ()2 336 ()1 629 ()1 093 ()2 227 ()
Insurance (%)
 Medicare81 230 (63)4 357 (66)14 881 (64)17 062 (64)13 497 (63)9 645 (63)21 788 (62)
 Medicaid6 777 ()194 ()989 ()1 358 ()1 225 ()897 ()2 114 ()
 Private12 156 ()623 ()2 344 ()2 718 ()2 138 ()1 414 ()2 919 ()
 Other28 435 (22)1 470 (22)5 100 (22)5 714 (21)4 627 (22)3 322 (22)8 202 (23)
Marital status (%)
 Married51 385 (40)3 057 (46)9 942 (43)10 888 (41)8 368 (39)5 934 (39)13 196 (38)
 Divorced8 725 ()434 ()1 462 ()1 778 ()1 470 ()1 055 ()2 526 ()
 Single29 615 (23)1 482 (22)4 939 (21)5 701 (21)4 873 (23)3 536 (23)9 084 (26)
 Widowed16 521 ()823 ()3 186 ()3 641 ()2 783 ()1 990 ()4 098 ()
Comorbidities (%)
 DM73 847 (57)3 353 (50)12 972 (56)15 550 (58)12 787 (60)9 147 (60)20 038 (57)
 HTN96 852 (79)4 986 (81)17 714 (80)20 485 (80)16 337 (80)11 560 (80)25 770 (78)
 IHD26 062 (21)1 287 (21)4 777 (22)5 549 (22)4 470 (22)3 192 (22)6 787 (20)
 CHF33 534 (28)1 475 (24)5 663 (26)7 005 (27)5 691 (28)4 249 (29)9 451 (28)
 PVD13 820 ()669 ()2 404 ()2 842 ()2 373 ()1 770 ()3 762 ()
 CVA9 015 ()482 ()1 628 ()1 928 ()1 632 ()1 025 ()2 320 ()
 COPD6 904 ()377 ()1 140 ()1 365 ()1 135 ()887 ()2 000 ()
 Malignancy5 538 ()209 ()829 ()1 019 ()879 ()622 ()1 980 ()
 Current smoking5 854 ()345 ()978 ()1 134 ()971 ()650 ()1 776 ()
BMI (kg/m2)26.6 ± 6.726.7 ± 6.526.2 ± 6.026.4 ± 6.426.7 ± 6.526.8 ± 6.927.1 ± 7.4
Laboratory parameters
 Hemoglobin (g/dL)12.1 ± 1.012.6 ± 0.812.4 ± 0.712.3 ± 0.812.2 ± 0.812.0 ± 0.911.5 ± 1.2
 Creatinine (mg/dL)8.2 ± 3.08.4 ± 3.28.4 ± 3.08.4 ± 3.08.3 ± 3.08.1 ± 3.08.0 ± 3.1
 Albumin (g/dL)3.7 ± 0.43.9 ± 0.33.9 ± 0.33.8 ± 0.43.7 ± 0.43.7 ± 0.43.5 ± 0.5
 TIBC (mg/dL)203 ± 41215 ± 36211 ± 36206 ± 37203 ± 39201 ± 40194 ± 46
 Calcium (mg/dL)9.3 ± 0.69.4 ± 0.69.4 ± 0.69.3 ± 0.69.3 ± 0.69.2 ± 0.69.1 ± 0.7
 Phosphorus (mg/dL)5.6 ± 1.35.4 ± 1.25.4 ± 1.15.5 ± 1.25.6 ± 1.35.6 ± 1.35.7 ± 1.4
 WBC (×103/mm3)7.4 ± 2.47.4 ± 2.27.4 ± 2.07.4 ± 2.17.4 ± 2.27.5 ± 2.47.5 ± 2.9
 Lymphocyte (%)20.3 ± 7.322.3 ± 7.421.7 ± 7.221.0 ± 7.220.3 ± 7.219.6 ± 7.218.8 ± 7.4
 Ferritin (ng/mL)515 (314,742)572 (377,777)554 (362,755)532 (341,741)509 (313,728)491 (291,730)473 (265,737)
 Single-pool 1.6 ± 0.31.7 ± 0.31.7 ± 0.31.6 ± 0.31.6 ± 0.31.6 ± 0.31.5 ± 0.3
 nPNA (g/kg/day)1.0 ± 0.21.0 ± 0.21.0 ± 0.21.0 ± 0.21.0 ± 0.21.0 ± 0.20.9 ± 0.2

Note: categorical variables are expressed as frequency (percentage). Continuous variables are given as mean ± SD or median (interquartile range) as appropriate.
Conversion factors for units: hemoglobin and albumin in g/dL to g/L ×10; creatinine in mg/dL to μmol/L ×88.4; calcium in mg/dL to mmol/L ×0.2495; and phosphorus in mg/dL to mmol/L ×0.3229. No conversion necessary for ferritin in ng/mL and μg/L and WBC count in 103/L and 109/L. DM = diabetes mellitus, HTN = hypertension, IHD = ischemic heart disease, CHF = congestive heart failure, PVD = peripheral vascular disease, CVA = cerebrovascular accident, COPD = chronic obstructive pulmonary disease, BMI = body mass index, TIBC = total iron binding capacity, WBC = white blood cell, and nPNA = normalized protein nitrogen appearance.